Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics.

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Anaplastic thyroid cancer (ATC) is a deadly malignancy that often arises from differentiated thyroid cancer (DTC).
• The intricate process of tumor transformation from DTC to ATC remains poorly understood.
• Investigating the cell lineage and fate transitions during this transformation is crucial for identifying therapeutic strategies.

Purpose of the Study:

• To elucidate the complex intratumor transformation process from differentiated thyroid cancer to anaplastic thyroid cancer.
• To identify key cellular and genetic milestones in the progression of thyroid cancer.
• To uncover novel therapeutic opportunities for anaplastic thyroid cancer.

Main Methods:

• Single-cell transcriptomic analysis of thyroid cancer patient samples.
• Analysis of genetic alterations across different thyroid cancer subtypes.
• Dissection of cell lineage and cell fate transitions during tumor progression.

Main Results:

• A spectrum of ATC transformation was identified, including stress-responsive DTC cells, inflammatory iATCs, and mesenchymal mATCs.
• Two key milestones were observed: a diploid inflammatory stage (iATCs) and an aneuploid mesenchymal stage (mATCs) characterized by collagen production.
• Immune cell reprogramming (macrophages and T cells) and cancer-associated fibroblast interactions were noted during transformation.

Conclusions:

• The study provides a detailed model of ATC transformation, highlighting distinct cellular phenotypes and genomic stages.
• Identification of diploid inflammatory and aneuploid mesenchymal stages offers insights into tumor evolution.
• Observed immune microenvironment changes and fibroblast interactions suggest potential therapeutic targets for anaplastic thyroid cancer treatment.